Dietary interventions in patients with type 2 diabetes (T2D) are important for preventing long-term complications. Although a healthy diet is crucial, there is still uncertainty about the optimal macronutrient composition. We performed a meta-analysis comparing diets high in cis-monounsaturated fatty acids (MUFA) to diets high in carbohydrates (CHO) or in polyunsaturated fatty acids (PUFA) on metabolic risk factors in patients with T2D.
Dietary interventions in patients with type 2 diabetes (T2D) are an important adjunct to physical activity, medication, and insulin therapy in the prevention of diabetes-associated complications, particularly cardiovascular disease (CVD) (1) . Current recommendations by the American Diabetes Association emphasize the inclusion of cis-monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) in the diet of individuals with T2D over intake of saturated fats and trans fatty acids (2) . Although the evidence for quantity of total fat intake is inconclusive, there is a growing body of evidence supporting the importance of the quality of fat (1, 3) for the prevention of CVD in this group. Results from the PREvención con DIeta MEDiterránea (PREDIMED) trial, which recruited individuals with prevalent T2D, also showed that diets high in olive oil and nuts, foods that are rich in MUFA, prevented CVD events in a high-risk population (4) . Foods rich in MUFA and PUFA have been shown to favorably impact blood lipid concentrations thus decreasing the risk of CVD (5, 6) . High-MUFA diets have gained significant attention as an alternative dietary pattern to the commonly recommended low-fat and high-carbohydrate (CHO) pattern. Several prior meta-analyses of randomized controlled trials (RCTs) suggested potential benefits of a high-MUFA diet compared with a high-CHO diet in improving metabolic factors, such as glycemic control, serum lipids, and blood pressure, among both healthy individuals and T2D patients (3, 5, 7) but were usually based on a relatively small number of studies/subjects or short duration of follow-up. Hence, there is still uncertainty regarding whether longer-term interventions that substitute MUFA for CHO will yield the same metabolic effects as short-term trials. Furthermore, many of the RCTs also implemented caloric restriction as part of the dietary intervention, which may impede long-term compliance. Thus we conducted an updated meta-analysis comparing high-MUFA to high-CHO diets on metabolic risk factors among patients with T2D. We also included a comparison between high-MUFA and high-PUFA diets, which has not been previously assessed in a systematic manner to our knowledge.
RESEARCH DESIGN AND METHODS
This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ( Fig. 1) (8) .
Data Sources and Searches
We searched PubMed, MEDLINE, Cochrane Central Register of Controlled Trials, and prior meta-analyses for articles up through 31 March 2015. The key words used to identify studies included "type 2 diabetes" or "type II diabetes" or "non-insulin diabetes"; "monounsaturated fatty acid" or "MUFA"; "polyunsaturated fatty acid" or "PUFA"; "glycemic" or "glucose" or "HbA 1c "; "lipid" or "cholesterol"; and "randomized" or "trial." The search was limited to RCTs that were published in English and had an intervention and follow-up duration of at least 2 weeks. Full details on our search terms and strategy for PubMed are shown in Supplementary Fig. 1 .
Study Selection
RCTs (either parallel or crossover designs) comparing the effects of high-CHO or high-PUFA diets (from plant sources or n-6) with those of high-MUFA diets on metabolic parameters among adults with T2D were included in the meta-analysis. Studies that included the additional use of medications or supplements, changes in physical activity, patients with type 1 diabetes or unconfirmed T2D/glucose intolerance, or interventions using n-3 fatty acids or other unspecified dietary changes were excluded. Detailed inclusion/exclusion criteria are shown in Supplementary  Table 1 . From the initial search results, one author (F.Q.) screened titles and abstracts and identified the full-text articles for inclusion in the meta-analysis. A second author (A.A.K.) confirmed that all articles that were included in the meta-analysis met the inclusion and exclusion criteria.
Data Extraction and Quality Assessment
Data were extracted independently by two authors (F.Q. and A.A.K.) and any discrepancies that arose were adjudicated by a third author (F.B.H.). The following information was extracted: study design (randomized parallel, randomized crossover, inpatient/outpatient), trial arms/sample size, study duration, mean dietary composition (percent of total energy), age of participants, baseline BMI, duration of diabetes, and means and SDs of changes in HbA 1c (%), fasting plasma glucose (mmol/L), fasting insulin (pmol/L), LDL cholesterol (mmol/L), HDL cholesterol (mmol/L), triglycerides (mmol/L), body weight (kg), and 24-h measurements of systolic blood pressure (mmHg) and diastolic blood pressure (mmHg) from baseline to the end of follow-up. Data were extracted from the primary publications with proper transformations done to harmonize the units used. Authors of original publications were contacted when necessary to obtain additional data.
Study Quality and Risk of Bias
RCTs meeting the inclusion criteria above were evaluated for risk of bias using the Cochrane Collaboration's tool for assessing risk of bias and were categorized as having a "high risk of bias," "low risk of bias," or "unclear risk of bias" (9) . Specifically, RCTs were reviewed for allocation concealment, blinding approaches, approaches for incomplete outcome data, selective reporting, and bias due to problems arising from other issues.
Data Synthesis and Analysis
Our outcome of interest was the weighted mean difference (WMD) from baseline to the end of follow-up in the metabolic parameters listed above between the high-MUFA diet and the high-CHO or high-PUFA diets. WMD was calculated using both the random-effects and fixed-effects models. We considered random-effects analysis the main focus of our meta-analysis. Subgroup analyses were conducted based on the age of participants, baseline BMI, duration of diabetes, MUFA replacement (difference in percent energy from MUFA in the intervention and control arms), duration of follow-up (weeks), and study design (parallel vs. crossover). Heterogeneity between trial results was tested with a standard x 2 test. The I 2 parameter was used to quantify any inconsistency:
, where Q is the x 2 statistic and d.f. is its degrees of freedom (10) . Meta-regressions involving the above baseline characteristics as both continuous and categorical variables were also performed to identify potential sources of heterogeneity. Publication bias was assessed visually with funnel plots and with Egger and Begg-Mazudumar regression tests (11, 12) . Sensitivity analyses in which each study was removed in turn to assess the influence of that study on the overall effect size were also conducted. Statistical analyses were conducted with Stata 13.0, including the metan module (StataCorp, College Station, TX).
RESULTS

Literature
A total of 615 records were identified in the initial search and 406 abstracts were selected for review after removing duplicates. After stage 1 screening, 53 records underwent full-text screening. Overall, 28 studies were included in the meta-analysis with 24 for MUFA vs. CHO diets (Table 2) , although there was considerable heterogeneity (HDL cholesterol I 2 = 45.4%, P = 0.010; triglycerides I 2 = 54.0%, P = 0.001) ( Table 2 ). Comparing a high-MUFA diet to a high-PUFA diet, there was a nonsignificant reduction in of LDL cholesterol and nonsignificant increases in HDL cholesterol and triglycerides (Table 3) .
Other Metabolic Effects
Body Weight
A high-MUFA diet compared with a high-CHO diet resulted in a significant mean decrease in body weight (WMD 21.56 kg [95% CI 22.89, 20.23]), with low heterogeneity (I 2 = 0.0%, P = 1.000) ( Table 2 ).
Blood Pressure
In examining 24-h blood pressure monitoring, a high-MUFA diet compared with a high-CHO diet resulted in a significant reduction in systolic blood pressure Meta-regressions were also performed for these outcomes using the baseline characteristics described above and we identified age (b = 0.50, P = 0.002) and BMI (b = 20.32, P = 0.011) as significant predictors for the effect on LDL cholesterol. This suggests that these factors may be potential sources of heterogeneity in these analyses.
Publication Bias and Risk of Bias
Statistically significant publication bias was not found for any of the main outcomes using both the Egger and the Begg-Mazudumar tests (Supplementary Table 2 ). This was also confirmed based on visual inspection of the corresponding funnel plot (Supplementary Fig. 3 ). No study exerted overt influence on the pooled effect size for any of the primary outcomes (data not shown). Furthermore, most studies were assessed to be of low risk for bias (Supplementary Table 3 ).
CONCLUSIONS
In our meta-analysis of RCTs, we observed beneficial effects of a high-MUFA diet compared with a high-CHO Values in boldface type indicate statistical significance at P , 0.05. *Calculated using a fixed-effects model. †Calculated using a random-effects model. Continued on p. 1454 diet on glycemic control, serum lipids, and systolic blood pressure among individuals with T2D, whereas a beneficial effect on fasting plasma glucose was observed for high-MUFA compared with high-PUFA diets. These improvements are important in the prevention of longterm complications in this population. In observational studies, substituting dietary MUFA for CHO or saturated fatty acids (SFA) has generally not been associated with a decreased risk of CVD (42) (43) (44) (45) (46) . However, this may be due to the fact that the main source of MUFA in the Western diet is from animalbased foods, including dairy and meat, which contain comparably higher levels of SFA compared with plant sources of Values in boldface type indicate statistical significance at P , 0.05. *Calculated using a fixed-effects model. †Calculated using a random-effects model. ‡Indicates % energy difference from MUFA in the intervention and control arms.
MUFA. In the current study, all of the trials evaluated plant sources of MUFA, such as olive oil, nuts, or avocado, which reduces the confounding by SFA intake observed in cohort studies. In several observational studies and meta-analyses, higher consumption of PUFA in place of SFA or CHO has been associated with lower rates of coronary events, though it is unclear whether substitution for MUFA would yield a similar benefit (43-46). Better glycemic control and improved insulin sensitivity have often been observed in subjects consuming a high-MUFA diet, particularly when MUFA was used to replace CHO (47) (48) (49) . The favorable increase in HDL cholesterol and reduction in triglycerides that we observed is also consistent with prior meta-analyses (5, 50) . These improvements are particularly important for the prevention of CVD among individuals with T2D given that the majority of this population has dyslipidemia. We observed a small reduction in systolic blood pressure, which is also consistent with the results from a prior metaanalysis (7). Our summary measures are consistent with a previous metaanalysis by Schwingshackl et al. (3) that reported significant reductions in HbA 1c when comparing high-MUFA to high-CHO diets and nonsignificant reductions in plasma insulin, plasma glucose, and HOMA-insulin resistance. The nonsignificant results of this previous analysis could be due to the fact that fewer studies were included for these measures. Garg et al. (5) also reported significant reductions in fasting glucose and a nonsignificant reduction in plasma insulin, also possibly due to the inclusion of fewer trials. Overall, the results for glycemic control favor high-MUFA compared with high-CHO diets, especially in the reduction of fasting plasma glucose. Moreover, we observed a modest but statistically significant difference in body weight on high-MUFA compared with high-CHO diets, both overall and in several subgroups. This finding suggests that the effects of the high-MUFA diets on the metabolic risk factors could be partially mediated by changes in body weight, which has been shown in prior studies evaluating blood lipids, blood pressure, and glycemic control (51, 52) .
Out of the outcomes we evaluated comparing high-MUFA to high-PUFA diets, we only observed a reduction in fasting plasma glucose. The overall lack of difference observed between these two diets on the metabolic risk factors we evaluated could be due to small sample sizes or similar metabolic effects between these two diets. In addition, the length of follow-up in these trials may have been too short to observe meaningful changes in the biomarkers. The intervention foods in the high-PUFA regimens varied from study to study (sunflower oil, nuts, corn oil) each containing other components (macro-and micronutrients, antioxidants) that may have influenced the results of a given trial due to their association with glycemic control or serum lipid levels (53) (54) (55) (56) .
Potential physiological mechanisms for the metabolic benefits observed when replacing CHO with MUFA are diminished glycemic load, leading to reduced demand for insulin, greater insulin sensitivity (57) , and increased hepatic LDL receptors, resulting in accelerated LDL cholesterol turnover while having no appreciable effect on total cholesterol synthesis (e.g., does not lower HDL cholesterol) (58) . There is also growing evidence that MUFA-rich foods, including olive oil and avocados, contain numerous other beneficial compounds such as phenolic compounds, plant phytochemicals, and fat-soluble vitamins (59) (60) (61) . Oleic acid, a MUFA, which is the primary component in olive oil, has been directly implicated in blood pressure reduction by increasing cell membrane fluidity and exerting hypotensive effects via the a 2 -adrenergic receptor system (62) .
Our results are consistent with recent findings from the PREDIMED trial, which observed a decrease in CVD incidence among individuals with T2D who followed a Mediterranean diet compared with a low-fat diet. This suggests that changes in metabolic indices may be predictive of clinical end points (4) . On the basis of our findings, body weight differed between the high-MUFA diet compared with the high-CHO diet. To account for the weight differences among these two diets, we performed a sensitivity analyses (Supplementary (63) . However, whether such an effect would be observed among obese individuals with T2D is not clear. Additional longer-term trials are needed to assess whether greater weight loss can be achieved with a high-MUFA diet among individuals with diabetes.
Our stratified analysis found modestly greater changes in several metabolic factors including HbA 1c , HDL cholesterol, and triglycerides in trials that were of longer duration (.6 vs. #6 weeks), suggesting that longer-term adherence to a high-MUFA diet may produce a more favorable metabolic profile. When we performed a sensitivity analysis and restricted the analysis to studies that were at least 3 months in duration, we observed a consistent or stronger effect on many of the metabolic parameters as in our overall analysis (Supplementary Table 6 ). Furthermore, this result is consistent with the nonsignificant reduction in HbA 1c (%), which is likely due to the relatively short duration of most studies in the meta-analysis; HbA 1c is more indicative of long-term glycemic control, over the span of 3-4 months. We tended to observe greater effects among studies using parallel rather than crossover designs, particularly for HDL cholesterol and triglycerides. This may be partially attributed to larger sample sizes in the parallel studies in our analysis. It is also possible that the duration of the washout period in the crossover trials was not sufficient to diminish a potential carryover effect. These subgroup findings may partially explain some of the heterogeneity observed in our effect estimates.
Our study has several strengths. We included both long-term and short-term studies in our overall and stratified analysis. In general, for studies evaluating MUFA compared with CHO diets, we selected studies that kept the percent of calories from protein and SFA consistent across the intervention and control arms. Similarly, for MUFA compared with PUFA diets, we selected studies that had minimal differences in the percent of calories from protein, CHO, and SFA. Furthermore, we sought to identify potential sources of heterogeneity in our study through both subgroup analysis and meta-regression, particularly for HbA 1c , HDL cholesterol, and triglycerides. In addition, no outcome was observed to have potential publication bias based on our assessment (Supplementary Table 2 ), as we attempted to minimize bias by contacting authors to obtain unpublished results when necessary. There are several limitations to our study. Our study only included studies that examined individuals with T2D or noninsulindependent diabetes; hence, it is unclear whether these metabolic benefits can be extended to individuals with impaired glucose tolerance or type 1 diabetes, although some studies suggest a similar benefit (3, 64) . Furthermore, we examined only metabolic risk factors that were consistently measured and reported in each study, but the benefits of a high-MUFA diet may also be mediated through effects on inflammation (65) , endothelial function (66) , and body fat distribution (67) , which all warrant further research. Most of the trials in our analysis were conducted among Western populations, which may limit the generalizability of our findings to other populations. In addition, comparisons of the foods consumed for the different diets in each study were generally not available. Hence, we cannot completely rule out the possibility that the metabolic differences we observed were attributable to some unmeasured dietary component. Finally, our analysis included a relatively small number of trials comparing high-MUFA to high-PUFA diets, which limits our conclusion regarding the metabolic effects of replacing MUFA with PUFA. Further studies are needed to examine whether replacement of CHO with PUFA exhibits similar metabolic benefits as MUFA among individuals with T2D.
In conclusion, our meta-analysis provides consistent evidence that replacing CHO with MUFA in the diet has beneficial effects on metabolic risk factors among individuals with T2D. Our findings have broad implications for dietary recommendations for this population.
